Commerce international · 10/12/20251 min de lecture
Grant of Interim Extension of the Term of U.S. Patent No. 7,319,099; Bitopertin (GlyT1 inhibitor) Oral Tablets
Traduction automatique locale · Langue originale de la source
Résumé
The United States Patent and Trademark Office has issued a certificate under 35 U.S.C. 156(d)(5) for a one-year interim extension of the term of U.S. Patent No. 7,319,099 ('099 patent).